These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37554492)

  • 1. Effect of music therapy on postembolization syndrome in Thai patients with hepatocellular carcinoma: A quasi-experimental crossover study.
    Khuntee W; Hanprasitkam K; Sumdaengrit B
    Belitung Nurs J; 2022; 8(5):396-404. PubMed ID: 37554492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.
    He JJ; Yin XX; Wang T; Chen MY; Li XL; Yang XJ; Shao HY
    J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial.
    Pan Y; Chang R; He Z; Hong M
    Medicine (Baltimore); 2021 Apr; 100(14):e25360. PubMed ID: 33832116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization.
    Arslan M; Degirmencioglu S
    Curr Med Imaging Rev; 2019; 15(4):380-385. PubMed ID: 31989907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer.
    Bian LF; Zhao XH; Gao BL; Zhang S; Ge GM; Zhan DD; Ye TT; Zheng Y
    World J Gastroenterol; 2020 Aug; 26(30):4442-4452. PubMed ID: 32874056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma.
    Simasingha N; Tanasoontrarat W; Claimon T; Sethasine S
    World J Gastroenterol; 2023 Feb; 29(5):890-903. PubMed ID: 36816622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.
    Roehlen N; Stoehr F; Müller L; Luxenburger H; Gairing SJ; Reincke M; Schultheiss M; Berisha F; Weinmann A; Foerster F; Marquardt JU; Thimme R; Galle PR; Bettinger D; Kloeckner R
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer.
    Blackburn H; West S
    Cancer Nurs; 2016; 39(5):E1-E18. PubMed ID: 26484962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
    Khalaf MH; Sundaram V; AbdelRazek Mohammed MA; Shah R; Khosla A; Jackson K; Desai M; Kothary N
    Radiology; 2019 Jan; 290(1):254-261. PubMed ID: 30299233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
    Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.
    Zhou ZG; Chen JB; Qiu HB; Wang RJ; Chen JC; Xu L; Chen MS; Zhang YJ
    Oncotarget; 2016 May; 7(19):27938-45. PubMed ID: 27056892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xu L; Wang S; Zhuang L; Lin J; Chen H; Zhu X; Bei W; Zhao Q; Wu H; Meng Z
    Integr Cancer Ther; 2016 Sep; 15(3):349-57. PubMed ID: 26590124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nausea and vomiting after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
    Wang SY; Zhu WH; Vargulick S; Lin SB; Meng ZQ
    Asian Pac J Cancer Prev; 2013; 14(10):5995-6000. PubMed ID: 24289614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Risk Factors of Post-chemoembolization Syndrome After Chemo-Embolization for Hepatocellular Carcinoma in Thailand.
    Thanakunchai T; Hongthanakorn C
    Dig Dis Sci; 2023 Sep; 68(9):3818-3823. PubMed ID: 37402085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of Prediction Model of Severe Abdominal Pain Post-Transarterial Chemoembolization in Patients with HBV-Associated Primary Liver Cancer.
    Yang Y; Chen S; Yan Z; Jiao Y; Yan X; Li Y
    Comput Math Methods Med; 2022; 2022():5203166. PubMed ID: 35941895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin.
    Sakamoto T; Saito Y; Kobayashi M; Yamada T; Takekuma Y; Nakai M; Ogawa K; Iseki K; Sugawara M
    Support Care Cancer; 2020 Jul; 28(7):3251-3257. PubMed ID: 31732854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
    Li XQ; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy.
    Feng R; Cheng DX; Song T; Chen L; Lu KP
    World J Gastrointest Surg; 2023 Apr; 15(4):687-697. PubMed ID: 37206075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
    BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
    AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.